ASX:ACL Australian Clinical Labs (ACL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Australian Clinical Labs Stock (ASX:ACL) 30 days 90 days 365 days Advanced Chart Get ACL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$728.27 millionP/E Ratio30.38Dividend Yield3.28%Price TargetN/AConsensus RatingN/A Company OverviewAustralian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.Read More… Receive ACL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address ACL Stock News HeadlinesLeadership Transition at Australian Clinical LabsApril 15, 2025 | tipranks.comAustralian Clinical Labs Updates Share Buy-Back ProgressApril 2, 2025 | tipranks.comGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.April 25, 2025 | Weiss Ratings (Ad)Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst institutional investors who own 62%March 28, 2025 | finance.yahoo.comAustralian Clinical Labs Sees Change in Substantial HoldersMarch 3, 2025 | tipranks.comAustralian Clinical Labs Issues New Securities to Bolster EquityMarch 2, 2025 | tipranks.comAustralian Clinical Labs' (ASX:ACL) Dividend Will Be A$0.035March 1, 2025 | finance.yahoo.comAustralian Clinical Labs Reaffirms FY25 Financial GuidanceFebruary 27, 2025 | tipranks.comSee More Headlines ACL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Australian Clinical Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Coles Group (COL). Company Calendar Ex-Dividend for 4/15 Dividend3/26/2025Record date for 4/15 Dividend4/15/2025Dividend Payable4/15/2025Today4/25/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:ACL CIKN/A Webwww.clinicallabs.com.au Phone61 3 9538 6777FaxN/AEmployees5,115Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.12 Trailing P/E Ratio30.38 Forward P/E RatioN/A P/E Growth-0.36Net Income$23.93 million Net Margins3.45% Pretax MarginN/A Return on Equity13.98% Return on Assets6.67% Debt Debt-to-Equity Ratio174.00 Current Ratio0.64 Quick Ratio0.53 Sales & Book Value Annual Sales$696.37 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares201,830,000Free FloatN/AMarket Cap$728.27 million OptionableNot Optionable Beta1.18 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (ASX:ACL) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Clinical Labs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Clinical Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.